In its upcoming report, Centene (CNC - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.89 per share, reflecting an increase of 656.3% compared to the same period last year. Revenues are forecasted to be $47.53 billion, representing a year-over-year decrease of 2.5%.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
That said, let's delve into the average estimates of some Centene metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Revenues- Service' at $722.97 million. The estimate indicates a year-over-year change of -0.6%.
Based on the collective assessment of analysts, 'Revenues- Premium' should arrive at $42.49 billion. The estimate points to a change of +1.8% from the year-ago quarter.
Analysts' assessment points toward 'Revenues- Premium and service revenues' reaching $43.22 billion. The estimate points to a change of +1.8% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Revenues- Premium tax' of $4.37 billion. The estimate points to a change of -30.3% from the year-ago quarter.
According to the collective judgment of analysts, 'Membership by line of business - Total' should come in at 25.87 million. Compared to the current estimate, the company reported 28.00 million in the same quarter of the previous year.
Analysts predict that the 'Membership by line of business - Medicaid' will reach 12.23 million. Compared to the current estimate, the company reported 12.82 million in the same quarter of the previous year.
The consensus estimate for 'Membership Medicaid - Traditional Medicaid' stands at 10.75 million. Compared to the present estimate, the company reported 11.23 million in the same quarter last year.
Analysts expect 'Membership by line of business - Medicare' to come in at 1.00 million. The estimate compares to the year-ago value of 1.03 million.
Analysts forecast 'Membership by line of business - Medicare PDP' to reach 8.79 million. Compared to the current estimate, the company reported 7.85 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Membership Medicaid - High Acuity Medicaid' will likely reach 1.47 million. Compared to the present estimate, the company reported 1.59 million in the same quarter last year.
It is projected by analysts that the 'Total Medical Health (Benefits) loss Ratios -Total Ratio (HBR)' will reach 91.5%. The estimate is in contrast to the year-ago figure of 93.0%.
The consensus among analysts is that 'Membership - Commercial' will reach 3.85 million. Compared to the current estimate, the company reported 6.31 million in the same quarter of the previous year.
View all Key Company Metrics for Centene here>>>
Centene shares have witnessed a change of +4.6% in the past month, in contrast to the Zacks S&P 500 composite's +0.4% move. With a Zacks Rank #3 (Hold), CNC is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Key Takeaways Centene is set to report Q2 2026 results on July 28, with EPS estimated at 89 cents on $47.53B revenue.CNC's profitability may improve from pricing, cost controls and portfolio optimization amid membership falls.The health benefits ratio is projected to improve to 91.5% from 93%, supporting margins. Healthcare plan provider Centene Corporation (CNC - Free Report) is set to report second-quarter 2026 results on July 28, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at 89 cents per share on revenues of $47.53 billion.
The second-quarter earnings estimate remained stable over the past 60 days. The bottom-line projection indicates a year-over-year improvement from a loss of 16 cents per share. However, the Zacks Consensus Estimate for quarterly revenues suggests a year-over-year decline of 2.5%.
Image Source: Zacks Investment Research
For 2026, the Zacks Consensus Estimate for Centene’s revenues is pegged at $190.97 billion, implying a fall of 2% year over year. Yet, the consensus mark for 2026 EPS is pegged at $3.46, signaling a growth of 66.4% year over year.
Centenebeat earnings estimates in three of the last four quarters and missed once, with the average surprise being 74.9%. This is depicted in the figure below.
Q2 Earnings Whispers for CenteneOur proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.
CNC has an Earnings ESP of 0.00% and a Zacks Rank #3. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
You can see the complete list of today’s Zacks #1 Rank stocks here.
What’s Shaping Centene’s Q2 Results?The Zacks Consensus Estimate for the company’s total commercial memberships indicates a 39.1% year-over-year decrease, primarily due to a decline in the commercial marketplace. The consensus estimate for the company’s total Medicaid memberships indicates a 4.6% decline from a year ago.
As such, the Zacks Consensus Estimate for total membership indicates a 7.6% year-over-year decline, which reflects its portfolio optimization efforts. However, the consensus mark for Medicare PDP memberships signals 12.1% growth from the year-ago quarter.
The consensus estimate projects the company’s premium growth at only 1.8% year over year. The consensus mark for the company’s investment and other income indicates a 3.2% year-over-year decline from $371 million. Moreover, the projection for service revenues indicates a 0.6% fall from the year-ago quarter’s $727 million. These are likely to have affected the second quarter top line.
Nevertheless, due to its cost-curbing efforts, better pricing and portfolio optimization, the bottom line is likely to have improved. The Zacks Consensus Estimate for the total health benefits ratio is pegged at 91.5%, down from 93% in the year-ago period, meaning a higher portion of premiums remaining in hand after paying claims.
CNC’s Price Performance & ValuationCentene's stock has gained 64.3% in the year-to-date period compared with the industry’s growth of 31%. Its peers, such as Humana Inc. (HUM - Free Report) and Molina Healthcare, Inc. (MOH - Free Report) , have jumped 57.9% and 30.5%, respectively, during this time. Meanwhile, the S&P 500 has only increased 9.5%.
YTD Price Performance – CNC, HUM, MOH, Industry & S&P 500 Image Source: Zacks Investment Research
Now, let’s look at the value Centene offers investors at current levels.
CNC is trading at 16.91X forward 12-month earnings, above its five-year median of 11.31X. But it is still below the industry’s average of 18.12X. In comparison, Humana and Molina Healthcare are currently trading at 31.75X and 31.80X, respectively.
Image Source: Zacks Investment Research
How Should You Play CNC Stock Now?The company has made meaningful progress in restoring profitability through disciplined pricing, portfolio optimization and cost-control initiatives following last year's setback. A healthier medical benefit ratio, stronger cash generation and improving performance in its Medicaid and Medicare businesses provide reasons for optimism, while the stock's sharp year-to-date rally reflects growing investor confidence in the turnaround.
However, expectations have also become more demanding. Membership declines tied to portfolio optimization are likely to weigh on revenue growth, and Centene remains exposed to policy changes affecting government-sponsored healthcare programs. Elevated operating costs, despite signs of moderation, and below-average capital efficiency also suggest that the turnaround is still a work in progress.
Given these factors, existing shareholders may prefer to hold the stock and monitor management's commentary on medical costs, reimbursement trends and membership growth after the earnings release. New investors, meanwhile, may benefit from waiting for greater clarity on the company's execution and full-year outlook before initiating positions.
Key Takeaways Centene has surged 66% YTD as improving execution, margins and outlook fueled its turnaround.CNC raised 2026 premium and service revenue guidance after a stronger first-quarter performance.Centene still faces policy, cost and competition risks despite stronger cash flow and profitability. Centene Corporation (CNC - Free Report) , one of the largest managed healthcare providers in the United States, has staged an impressive comeback in 2026. The stock has surged 66% year to date, far ahead of the industry’s 28.5% gain. The broader S&P 500 has advanced 10.7% over the same period, while UnitedHealth Group Incorporated (UNH - Free Report) and Elevance Health, Inc. (ELV - Free Report) have returned 30% and 21.3%, respectively.
The rally marks a sharp reversal from last year's selloff, when rising medical costs forced Centene to withdraw its financial guidance and shook investor confidence. Since then, the company has regained visibility into its business, restored earnings growth and convinced investors that its turnaround is gaining traction. Better execution, improving profitability and a more favorable outlook for managed care have all helped drive the stock higher.
YTD Price Performance: CNC, UNH, ELV, Industry & S&P 500 Image Source: Zacks Investment Research
The first quarter reflected that progress. Centene's health benefits ratio improved 20 basis points from the prior-year period to 87.3%, while premium revenues increased 5.2% year over year to $43.9 billion, supported by higher Prescription Drug Plan (PDP) enrollment and stronger Medicaid reimbursement rates. The balance sheet also improved, with long-term debt declining 6% from year-end 2025 to $16.3 billion. Encouraged by these trends, management raised its 2026 premium and service revenue guidance to a range of $171-$175 billion from the previous outlook of $170-$174 billion.
What Do the Estimates Say Now?The Zacks Consensus Estimate for 2026 earnings is pegged at $3.46 per share, representing a 66.4% increase from the prior year. Analysts expect another year of growth in 2027, with earnings projected to reach $4.41 per share.
Revenue tells a different story. Estimates call for revenues of $191.03 billion in 2026, down 1.9% year over year, followed by a slight decline to $190.33 billion in 2027. Even so, investors appear focused on margin improvement rather than top-line growth.
Centene has beaten earnings estimates in three of the past four quarters, delivering an average surprise of 74.9%.
CNC’s ValuationCentene's strong share price performance has naturally lifted its valuation. The stock now trades at a forward price-to-earnings multiple of 17.22X, well above its five-year median of 11.31X. However, it still trades below the industry average of 18.48X. Compared with UnitedHealth at 21.84X and Elevance at 15.15X, Centene sits somewhere in the middle and carries a Value Score of A, suggesting the stock still offers a reasonable balance between price and earnings potential.
Image Source: Zacks Investment Research
Challenges Still Deserve AttentionDespite the recovery, several risks remain. Centene generates most of its revenues from government-sponsored healthcare programs, leaving results closely tied to changes in federal and state policies. Medicaid, Medicare and Affordable Care Act Marketplace plans all depend on reimbursement rates, funding decisions and evolving regulations.
Costs also remain a concern. Total operating expenses increased 5.5% in 2023, 5.8% in 2024 and 26.6% in 2025. During the first quarter of 2026, operating expenses rose another 6.6% year over year. Although management continues to adjust pricing and tighten cost controls, elevated medical costs and ongoing investments could slow the pace of margin improvement.
Capital efficiency also trails peers. Centene's trailing 12-month return on invested capital stands at 4.5%, below the industry average of 5.5%, suggesting there is still room to improve how the company deploys capital.
What Is Working in CNC’s Favor?Several factors continue to strengthen Centene's long-term outlook. Total membership eased to 26.3 million at the end of the first quarter as the company reshaped its portfolio, but growth is shifting toward businesses with better profitability. PDP membership increased 11.6% year over year, while Medicare Advantage and Dual-Eligible Special Needs Plan retention improved.
The Medicaid business remains another important driver. Improving state reimbursement rates and disciplined pricing are helping lift profitability in one of Centene's largest operations, although competition for new government contracts remains intense.
Management is also focused on improving efficiency. The merger of Carolina Complete Health and WellCare of North Carolina into a single provider-led organization creates a combined business serving more than 980,000 members, including more than 775,000 Medicaid members. The move should deepen relationships with providers while improving care coordination.
Cash generation has strengthened as earnings recover. Net cash from operations climbed to $4.4 billion in the first quarter from $1.5 billion a year earlier. Combined with favorable demographic trends, including an aging population and rising chronic disease rates, this gives Centene a stronger foundation for sustained growth.
Should Investors Buy CNC Stock Now?Centene has made meaningful progress in rebuilding investor confidence after a difficult 2025. Improving margins, cash generation, balance sheet and an encouraging earnings outlook suggest that the turnaround is gaining momentum. At the same time, the company continues to face familiar challenges, including policy uncertainty, elevated medical costs and intense competition across government-sponsored healthcare programs.
While the stock's sharp rally has reduced some of its valuation appeal, it still trades below the industry average and offers solid long-term fundamentals. With both positive catalysts and lingering risks in play, investors may want to wait for additional evidence of sustained earnings improvement. Centene currently carries a Zacks Rank #3 (Hold), indicating that existing shareholders can stay invested, while new investors may consider waiting for a more attractive entry point. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways CNC's Meridian won a four-year Illinois Medicaid contract renewal through 2030 under HealthChoice Illinois.CNC's renewal preserves a major membership base, supporting premium revenue visibility and growth stability.Centene's Medicaid revenues rose 6% year over year to $23.6 billion in first-quarter 2026. Centene Corporation’s (CNC - Free Report) subsidiary, Meridian Health Plan of Illinois, has secured a four-year renewal of its contract under the state's HealthChoice Illinois Medicaid program. The contract runs from Jan. 1, 2027, through 2030. Meridian is one of the six managed care organizations selected to provide services under the HealthChoice Illinois Medicaid program. The agreement ensures continued access to integrated primary, maternal and behavioral healthcare services for Medicaid members across Illinois.
Building on nearly 20 years of serving Illinois communities, Meridian continues to cover more than 596,000 Medicaid members. The renewal follows strong operational performance, with Meridian earning the state's highest 5-star rating on the latest HealthChoice Illinois Report Card for Access to Care, Living with Illness, and Women's and Children's Health. The agreement reinforces Centene's competitive position in the Illinois Medicaid market.
Medicaid remains Centene's largest business, with Medicaid revenues increasing 6% year over year to $23.6 billion in the first quarter of 2026. Given its heavy reliance on government-sponsored healthcare programs, the renewed Illinois contract supports premium revenue visibility and lowers the risk of future enrollment losses.
The announcement is not a game changer. It is unlikely to materially boost near-term earnings, but it preserves a significant source of premium revenues and enhances long-term earnings visibility. The renewal provides added confidence that Centene can maintain a stable Medicaid membership base and generate more predictable revenues from one of its core businesses.
How Are Competitors Faring?Some of CNC's major competitors in the managed care space are Humana Inc. (HUM - Free Report) and Molina Healthcare, Inc. (MOH - Free Report) .
Humana also secured a statewide contract under Illinois' HealthChoice Illinois Medicaid program, reinforcing its presence in the state's Medicaid managed care market. The contract expands HUM's government-sponsored healthcare business and supports long-term membership growth. Even so, Medicaid is not as significant an earnings driver for HUM as it is for Centene.
Molina Healthcare relies heavily on state Medicaid contracts, which are a key driver of membership and premium revenues. MOH depends on retaining and expanding these contracts to sustain growth and earnings visibility. Continued success in state Medicaid procurements strengthens MOH's competitive position and supports long-term revenue stability.
Centene’s Price Performance, Valuation & EstimatesShares of CNC have rallied 64.3% in the year-to-date period compared with the industry’s growth of 28.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 17.09, below the industry average of 18.5. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.46 per share, implying 66.4% growth from the year-ago period’s level.
Image Source: Zacks Investment Research
CNC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
, /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 second quarter financial results at approximately 6:00 a.m. ET on Tuesday, July 28, 2026, and host a conference call at 8:30 a.m. ET to review the results.
Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 4306002 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.
A webcast replay will be available for on-demand listening shortly following the completion of the call for the next 12 months or until 11:59 p.m. ET on Tuesday, July 27, 2027, at the aforementioned URL. In addition, a digital audio playback will be available until 9 a.m. ET on Tuesday, August 4, 2026, by dialing 1-855-669-9658 (toll free) in North America, or +1-412-317-0088 (toll) from abroad, and entering access code 6500508.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.
Centene Corporation's CNC margin recovery story appears to be shifting from strategy to execution. The company has rolled out several initiatives to better manage medical costs, modernize and standardize processes, and strengthen payment integrity.
, /PRNewswire/ -- Centene Corporation (Centene) (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Illinois subsidiary, Meridian Health Plan of Illinois, Inc. (Meridian), has been selected by the Illinois Department of Healthcare and Family Services (HFS) to continue providing services for the HealthChoice Illinois Medicaid managed care program. The four-year contract is expected to begin January 1, 2027, through 2030.
Meridian logo "Centene has a long track record serving Medicaid and dually eligible Medicaid-Medicare members in Illinois," said Chief Executive Officer Sarah M. London. "This award reflects Meridian's strong local partnerships and focus on delivering coordinated, high-quality care while connecting people to the support they need beyond the clinical setting. We value our partnership with the state and look forward to continuing to expand access and strengthen outcomes across Illinois."
Meridian is one of six managed care organizations selected by HFS to deliver access to high-quality managed care services to approximately 2.4 million Medicaid-eligible Illinoisans statewide. As of May 2026, Meridian serves more than 596,000 Medicaid enrollees through the HealthChoice Illinois Medicaid program. Under the new contract, Meridian will continue providing managed care for Medicaid enrollees, including access to integrated primary, maternal, and behavioral health care.
"We are honored to be chosen again by the Illinois Department of Healthcare and Family Services to continue delivering access to high-quality, whole person care through proven performance and building on our strategy to address barriers to care," said Meridian Plan President and Chief Executive Officer Cristal Gary.
In addition to ensuring its members get the medical care they need through its clinical and population health programs, Meridian's whole-person approach also focuses on improving well-being by working with community-based partners to address gaps in social drivers that impact health outcomes. Meridian is recognized for its work with the highest possible 5-star rating in the latest 2024 HealthChoice Illinois Report Card in three critical areas: Access to Care, Living with Illness, and Women's/Children's Health.
Building on nearly 20 years of experience serving Illinois communities, Meridian will continue providing comprehensive, coordinated care for some of the state's most vulnerable populations while advancing programs that address social drivers of health across all 102 counties.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.
About Meridian Health Plan of Illinois
Meridian Health Plan of Illinois, Inc. and its family of health plans provide government-sponsored managed care to families, children, seniors, and individuals with complex medical needs. This includes Meridian's Medicaid and Medicare-Medicaid plans, and YouthCare HealthChoice Illinois. YouthCare is a specialized program designed to address the healthcare needs of Illinois Department of Children and Family Services (DCFS) youth in out-of-home placement and former youth in care. Meridian connects members to care and offers comprehensive services to support lifelong health and wellness. Meridian is a company of Centene Corporation, a leading healthcare enterprise committed to helping people live healthier lives. Learn more at ILmeridian.com.
All statements, other than statements of current or historical fact, contained in this press release are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "predict," "intend," "seek," "target," "goal," "potential," "may," "will," "would," "could," "should," "can," "continue," and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our expected future operating or financial performance, changes in laws and regulations, market opportunity, expectations concerning pricing actions, competition, expected contract start dates and terms, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions. All forward-looking statements included in this press release are based on information available to us on the date hereof. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events, or otherwise, after the date hereof. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables, and events including, but not limited to: our ability to design and price products that are competitive and/or actuarially sound; our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical costs; rate cuts, insufficient rate changes or other payment reductions or delays by government payors affecting our government businesses; the effect of social, economic, and political conditions, geopolitical events and state and federal policies, including the amount and terms of state and federal funding for government-sponsored healthcare programs, including as a result of changes in U.S. presidential administrations or Congress; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder, including the timing and terms of renewal or modification of the Enhanced Advance Premium Tax Credits (eAPTCs) or program integrity initiatives that could have the effect of reducing membership or profitability of our products; unanticipated increased healthcare costs, including due to changes in consumer and provider behaviors, inflation and tariffs; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that could impact revenue and future growth; competition, including for providers, broker distribution networks, contract reprocurements and organic growth; our ability to adequately anticipate demand and timely provide for operational resources to maintain service level requirements in compliance with the terms of our contracts and state and federal regulations; our ability to comply with the terms of our contracts and state and federal regulations and our ability to effectively oversee our third-party vendors to comply with the terms of their contracts with us and state and federal regulations; our ability to manage our information systems effectively; disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in our relationships with third-party vendors; impairments to real estate, investments, goodwill and intangible assets; changes in senior management, loss of one or more key personnel or an inability to attract, hire, integrate and retain skilled personnel; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; our ability to effectively and ethically use artificial intelligence and machine learning in compliance with applicable laws; changes in macroeconomic conditions, including inflation, interest rates and volatility in the financial markets; negative public perception of the Company and the managed care industry; uncertainty concerning government shutdowns, debt ceilings or funding; tax matters; disasters, climate-related incidents, acts of war or aggression or major epidemics; changes in expected contract start dates and terms; changes in provider, broker, vendor, state, federal and other contracts and delays in the timing of regulatory approval of contracts, including due to protests and our ability to timely comply with any such changes to our contractual requirements or manage any unexpected delays in regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare or other customers); the difficulty of predicting the timing or outcome of legal or regulatory audits, investigations, proceedings or matters including, but not limited to, our ability to resolve claims and/or allegations on acceptable terms, or at all, or whether additional claims, reviews or investigations will be brought; challenges to our contract awards; cyber-attacks or other data security incidents or our failure to comply with applicable privacy, data or security laws and regulations; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the terms of our contracts and the undertakings in connection with any regulatory, governmental, or third party consents or approvals for acquisitions or dispositions; any changes in expected closing dates, estimated purchase price, or accretion for acquisitions or dispositions; losses in our investment portfolio; restrictions and limitations in connection with our indebtedness; a downgrade of our corporate family rating, issuer rating or credit rating of our indebtedness; the availability of debt and equity financing on terms that are favorable to us and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission (SEC). This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition, and results of operations, in our filings with the SEC, including our annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative (SG&A) costs.
Key Takeaways Centene is expanding AI-enabled fraud detection and payment integrity to improve medical cost efficiency.CNC improved Medicaid health benefits ratio to 93.1% as adjusted EPS rose 16.2% YoY in Q1 2026.Centene raised 2026 adjusted EPS guidance to more than $3.40 after a stronger first quarter. Centene Corporation (CNC - Free Report) is intensifying its efforts to curb fraud, waste and abuse as part of a broader strategy to improve profitability across its government-sponsored healthcare businesses. The company is expanding payment integrity capabilities by combining advanced analytics with AI-enabled tools to identify suspicious billing patterns, abnormal claims activity and emerging medical cost trends earlier. These initiatives are likely supporting CNC in strengthening cost controls while protecting taxpayer-funded healthcare programs.
The strategy is gaining traction in Medicaid, where the company has enhanced oversight of providers, particularly in applied behavior analysis services, while advocating program reforms that would allow states to take a more proactive approach to fraud prevention. Its ongoing investments in utilization management, network optimization and clinical programs create a multi-layered framework to improve medical cost efficiency. These efforts contributed to continued progress in Medicaid margins during the first quarter of 2026.
In the first quarter of 2026, adjusted earnings per share (EPS) rose 16.2% year over year to $3.37. Medicaid's health benefits ratio improved 50 bps year over year to 93.1%, reflecting better medical cost management and ongoing operational improvements. Encouraged by the strong start, Centene raised its 2026 adjusted EPS guidance to more than $3.40 from above $3.00 previously.
While healthcare cost trends remain challenging, Centene's growing focus on fraud prevention, payment integrity and AI-driven analytics could strengthen margin recovery over time. If execution remains consistent, these initiatives may provide a durable competitive advantage while supporting sustainable earnings growth.
How Are Competitors Faring?Some of CNC’s major competitors in the healthcare service provider space are UnitedHealth Group Incorporated (UNH - Free Report) and Elevance Health, Inc. (ELV - Free Report) .
UnitedHealth Group continues to strengthen payment integrity through advanced analytics, AI-driven claims monitoring and Optum's data capabilities. In the first quarter of 2026, UNH’s medical care ratio improved 90 bps year over year to 83.9%. The company remains focused on detecting billing irregularities, improving claims accuracy and managing medical costs, supporting long-term operational efficiency.
Elevance Health is enhancing fraud prevention by leveraging predictive analytics, automation and provider oversight to improve payment integrity. ELV is investing in data-driven care management and claims review capabilities, helping control medical costs while improving program integrity across its government-sponsored health plans.
Centene’s Price Performance, Valuation & EstimatesShares of CNC have surged 64.9% in the year-to-date period compared with the industry’s rise of 28.4%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 17.24, below the industry average of 18.52. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.46 per share, implying 66.4% growth from the year-ago period.
Image Source: Zacks Investment Research
CNC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Centene offers a defensive shelter as the AI infrastructure market faces skepticism and volatility. ACA insurance exchanges suffered adverse selection as healthy individuals exited, leaving a sicker, costlier pool. Regulatory shifts and flawed industry algorithms led to unexpected losses for insurers unable to adjust patient mix.
Key Takeaways CNC's integrated healthcare model supports earnings through coordinated care, pharmacy and clinical services.CNC raised its 2026 adjusted EPS guidance after Q1 adjusted EPS rose 16.2% YoY and revenues increased 5.1%.Centene is expanding AI, analytics and value-based care to improve costs, pricing and care quality. Centene Corporation's (CNC - Free Report) integrated healthcare model is supporting its earnings potential by combining government-sponsored health plans with coordinated clinical services, pharmacy benefits and community-based care. This approach helps the company to manage medical costs more effectively while improving health outcomes across Medicaid, Medicare and Commercial members. As of March 31, 2026, Centene served 26.3 million members, giving the company significant scale to spread administrative costs and support operating leverage.
Centene is also sharpening its operational capabilities through technology and data-driven initiatives. It expanded the use of advanced analytics and selective AI-enabled tools across medical economics, forecasting, fraud detection and payment integrity. These initiatives are helping identify emerging healthcare trends earlier, strengthen claims oversight and improve pricing decisions. In Medicare, the company continues to simplify provider contracts and expand value-based care models targeting high-cost specialties, supporting better quality and lower total cost of care.
In the first quarter of 2026, adjusted earnings per share increased 16.2% year over year to $3.37, while premium and service revenues rose 5.1%. Medicaid's health benefits ratio improved 50 bps year over year to 93.1%, reflecting the impact of better reimbursement, disciplined medical cost management and ongoing operational improvements. Encouraged by the strong start, Centene raised its 2026 adjusted EPS guidance to more than $3.40.
However, regulatory changes and medical cost trends remain key challenges. CNC's integrated approach is creating a stronger operating foundation. Continued investments in technology, clinical programs and provider partnerships should support margin recovery and position the company for sustainable earnings growth over the long term.
How Are Competitors Faring?Some of CNC’s major competitors in the value-based care space are UnitedHealth Group Incorporated (UNH - Free Report) and Elevance Health, Inc. (ELV - Free Report) .
UnitedHealth continues to strengthen its integrated healthcare platform by combining UnitedHealthcare's insurance operations with Optum's pharmacy, care delivery and health services businesses. This connected model enhances care coordination, improves operational efficiency and supports UNH’s long-term earnings growth through diversified revenue streams.
Elevance Health is expanding its integrated care strategy through Carelon, which combines pharmacy, behavioral health and care management services. ELV is leveraging these capabilities to improve clinical outcomes, manage medical costs more effectively and support sustainable earnings growth across its government-sponsored and commercial businesses.
Centene’s Price Performance, Valuation & EstimatesShares of CNC have rallied 66.1% in the year-to-date period compared with the industry’s rise of 36.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, Centene trades at a forward price-to-earnings ratio of 17.39, below the industry average of 19.69. CNC carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.46 per share, implying 66.4% growth from the year-ago period.
Image Source: Zacks Investment Research
CNC stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 25:
Cboe Global Markets, Inc. (CBOE - Free Report) : This derivatives and securities exchange network carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.
Cboe has a PEG ratio of 1.15 compared with 1.60 for the industry. The company possesses a Growth Score of A.
Centene Corporation (CNC - Free Report) : This managed care company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.3% over the last 60 days.
Centene has a PEG ratio of 0.49 compared with 1.06 for the industry. The company possesses a Growth Score of A.
Credo Technology Group Holding Ltd (CRDO - Free Report) : This high-speed connectivity solutions company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.5% over the last 60 days.
Credo Technology has a PEG ratio of 1.17 compared with 1.26 for the industry. The company possesses a Growth Score of B.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Learn more about the Growth score and how it is calculated here.
, /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced the appointment of Lauren M. Tyler to its Board of Directors, effective June 19, 2026. Ms. Tyler will serve on the Audit Committee and Compensation and Talent Committee.
Ms. Tyler brings more than 30 years of leadership experience across investment banking, private equity, corporate audit, investor relations, and human capital strategy.
CENTENE APPOINTS LAUREN M. TYLER TO BOARD OF DIRECTORS "Lauren's longstanding track record guiding global, complex organizations through transformation while prioritizing governance, talent development, and operational rigor will be key as Centene continues to evolve and deliver on its mission," said CEO Sarah M. London.
Ms. Tyler spent over two decades at JPMorgan Chase & Co., where she held senior roles including Executive Vice President and Global Head of Human Resources for Asset and Wealth Management, Global Firmwide Chief Auditor, and Global Head of Investor Relations. Earlier in her career, she held roles at TSG Capital Partners, Allen & Company, and Morgan Stanley.
She currently serves on the boards of Cencora, Inc., and Guardian Life. She previously served on the board of Alleghany Corporation until its acquisition in 2022. Ms. Tyler holds an MBA from Harvard Business School and a BA from Yale University.
"Lauren's seasoned board experience and proven leadership guiding complex organizations through dynamic operating environments will make her a strong addition to our Board," said Chairman Frederick H. Eppinger.
"I am honored to join Centene's Board, a company whose mission I deeply admire, and look forward to working closely with the company's leadership to make an impact on improving the health of the communities it serves nationwide," said Ms. Tyler.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach with local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured individuals. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com/.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank A proprietary stock-rating model, the Zacks Rank utilizes the power of earnings estimate revisions, or changes to a company's earnings outlook, to help investors create a successful portfolio.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Centene (CNC - Free Report) Centene Corporation is a well-diversified healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services.
CNC is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 18.38; value investors should take notice.
Nine analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.46 to $3.47 per share. CNC boasts an average earnings surprise of +74.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, CNC should be on investors' short list.
, /PRNewswire/ -- Following Gov. Newsom's declaration of a State of Emergency in Los Angeles County, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), is taking immediate action to support those affected by the fire. The company's priority is ensuring both its members and healthcare providers have the resources they need during this critical time.
Member Prescription Information
During a declared State of Emergency, impacted members have two options to secure an emergency supply of their medications:
Members can fill their prescription at the original pharmacy if it is open. If the original pharmacy is not open, members can call Health Net at 1-800-400-8987. We will suspend refill limitations so they can get their prescriptions at an out-of-network pharmacy. Coping Support for Members
Members can call Health Net Behavioral Health Services for crisis support 24 hours a day, seven days a week by calling 1-800-400-8987 (TTY: 711). This includes:
Support to help them deal with grief, stress or trauma Referrals to mental health counselors, local services and telephone consultations Members: Video Medical Appointments
If members cannot reach their primary care provider during a declared State of Emergency, Health Net offers telehealth services at no cost. Members can find appointment instructions in two places:
On the back of their Health Net ID card On HealthNet.com after registering and signing in Access to Social Services
To connect with local community resources, members can call 2-1-1 or visit 211.org for help with:
Emergency shelter, food and transportation Social services and financial assistance Legal guidance from verified agencies Information for Healthcare Providers
During a declared State of Emergency, doctors and nurse practitioners may call Health Net at 1-800-641-7761 for assistance. To support these participating providers in affected areas, Health Net will:
Extend grace periods for notifications, beginning on the admission date, for acute services, post-acute care, durable medical equipment (DME), medical supplies and home health care services Waive prior authorization – however, our notification requirement will remain in effect despite relaxed deadlines In addition, Health Net will:
Authorize out-of-network services if a contracting provider or facility becomes unavailable Grant post-admission notification approvals for impacted facilities. Accept updated clinical documentation for continued-stay reviews. Authorize the replacement of medical equipment or supplies. Suspend prescription refill limitations for impacted enrollees Ongoing Support & Updates
As the situation evolves, Health Net may take further action to support members and providers. For the latest updates, visit HealthNet.com.
About Health Net
Founded in California more than 45 years ago, Health Net, a company of Centene Corporation, believes that every person deserves a safety net for their health, regardless of age, income, employment status or current state of health. Today, we provide health plans for individuals, families, businesses of every size and people who qualify for Medi-Cal or Medicare. With more than 117,000 of our network providers, Health Net serves more than three million members across the state. We also offer access to substance abuse programs, behavioral health services, employee assistance programs and managed healthcare products related to prescription drugs. We make these health plans and services available through Health Net, LLC and its subsidiaries: Health Net of California, Inc., Health Net Life Insurance Company and Health Net Community Solutions, Inc. These entities are wholly owned subsidiaries of Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to transforming the health of the communities we serve, one person at a time. Health Net and Centene employ more than 5,700 people in California who work at one of five regional Talent Hub offices. For more information, visit www.HealthNet.com.
, /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX: CNIKF) has appointed SB1 Markets AS ("SB1 Markets") as exclusive advisor to arrange debt financing of up to US$600 million. The facility would allow the Company to monetize Investment Tax Credits expected to be generated by the construction of its Crawford Nickel Project. The Company expects the financing to be arranged by the end of 2026, in advance of a final investment decision on Crawford targeted for 2027. There can be no assurance that the proposed financing will be completed, and, if completed, the terms of such financing would be included in a subsequent release.
Mark Selby, CEO and Director of Canada Nickel Company said, "We are very pleased to work with SB1 Markets, a global leader with deep experience and a highly successful track record in providing debt financing for natural resource projects. With a final permitting decision expected shortly, we can now move more aggressively on key components of our project financing as we advance towards a final investment decision. This bridge financing is central to Crawford's overall capital structure; it allows us to deploy Canada's generous investment tax credits available for critical mineral projects in Canada to fund more than half of the equity capital we need to build Crawford."
About SB1 Markets
SB1 Markets AS is a leading Nordic investment bank, jointly owned by SpareBank 1 and Swedbank and providing investment banking services across DCM, ECM, advisory, research, sales, corporate access, and FICC. The firm is headquartered in Norway and Sweden with around 270 professionals. SB1 Markets has arranged transactions for a total value of approximately USD 70bn over the last twelve months and financing natural resource companies and projects is a core part of the company's business.
About Canada Nickel
Canada Nickel is advancing the next generation of nickel-sulphide projects to deliver nickel required to feed the high growth electric vehicle and stainless steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero NickelTM, NetZero CobaltTM and NetZero IronTM and is pursuing the development of processes to allow the production of net zero carbon nickel, cobalt, and iron products. Canada Nickel provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information, please visit www.canadanickel.com.
For further information, please contact:
Mark Selby
CEO
Phone: 647-256-1954
Email: [email protected]
This press release contains certain information that may constitute "forward-looking information" under applicable Canadian securities legislation. Forward looking information includes the ability of the Company to qualify for critical minerals tax credits, complete the financing described in this release and otherwise finance and construct the Crawford Nickel Project, deliver nickel required to feed the high growth electric vehicle and stainless steel markets, and the development of processes to allow the production of net zero carbon nickel, cobalt, and iron products. Readers should not place undue reliance on forward looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Canada Nickel to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. There are no assurances that Crawford will be placed into production. Factors that could affect the outcome include, among others: inability to repay the loan or comply with the covenants set out in the loan agreement; the ability to obtain the approval of the TSX Venture Exchange for the matters described herein; the actual results of development activities; project delays; inability to raise the funds necessary to complete development; general business, economic, competitive, political and social uncertainties; future prices of metals or project costs could differ substantially and make any commercialization uneconomic; availability of alternative nickel sources or substitutes; actual nickel recovery; conclusions of economic evaluations; changes in applicable laws; changes in project parameters as plans continue to be refined; accidents, labour disputes, the availability and productivity of skilled labour and other risks of the mining industry; political instability, terrorism, insurrection or war; delays in obtaining governmental approvals, necessary permitting or in the completion of development or construction activities; mineral resource estimates relating to Crawford could prove to be inaccurate for any reason whatsoever; additional but currently unforeseen work may be required to advance to the feasibility stage; and even if Crawford goes into production, there is no assurance that operations will be profitable. Although Canada Nickel has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this news release and Canada Nickel disclaims any obligation to update any forward looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.
In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.
One company value investors might notice is Centene (CNC - Free Report) . CNC is currently sporting a Zacks Rank #1 (Strong Buy), as well as an A grade for Value. The stock has a Forward P/E ratio of 12.35. This compares to its industry's average Forward P/E of 18.06. Over the past 52 weeks, CNC's Forward P/E has been as high as 13.40 and as low as 4.41, with a median of 8.43.
Investors will also notice that CNC has a PEG ratio of 0.82. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. CNC's PEG compares to its industry's average PEG of 0.93. Within the past year, CNC's PEG has been as high as 0.98 and as low as 0.38, with a median of 0.77.
Value investors also use the P/S ratio. The P/S ratio is calculated as price divided by sales. Some people prefer this metric because sales are harder to manipulate on an income statement. This means it could be a truer performance indicator. CNC has a P/S ratio of 0.15. This compares to its industry's average P/S of 0.32.
These figures are just a handful of the metrics value investors tend to look at, but they help show that Centene is likely being undervalued right now. Considering this, as well as the strength of its earnings outlook, CNC feels like a great value stock at the moment.
Morris Village development will expand access to long-term housing stability for families and individuals in Stanislaus County
, /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), announced a $4 million grant award to Self-Help Enterprises to support the development of Morris Village, a new 45-unit affordable housing community located in Modesto, California.
This investment will help bring more affordable housing to Modesto residents facing housing instability and ongoing health issues.
"Safe, stable housing can make a lasting difference in a person's health and well-being," said Dorothy Seleski, President of Medi-Cal at Health Net. "Our $4 million investment in Morris Village reflects our commitment to addressing the root causes of poor health outcomes in the communities we serve. When people with serious health needs have a stable place to call home, they are better able to manage their conditions, stay connected to care, and build a more secure future. We're proud to partner with Self-Help Enterprises to help bring this community to life in Modesto."
Health Net's grant will help Self-Help Enterprises close the project's remaining funding gap so it can begin construction. The 44 affordable homes will support residents earning below the median income for the area.
"Affordable housing is one of the most urgent needs facing families across Stanislaus County, and Morris Village represents exactly the kind of investment our community deserves," said Stanislaus County Supervisor Mani Grewal. "Health Net's $4 million commitment, combined with the expertise and dedication of Self-Help Enterprises, will help Modesto residents build healthier lives, stronger neighborhoods, and a more resilient community. I am proud to support this project and grateful to Health Net and Self-Help Enterprises for their support."
Self-Health Enterprises anticipates construction to begin in the fourth quarter of 2026 and be completed in spring of 2028.
"Morris Village will bring 45 much-needed affordable homes to Modesto—homes that do more than provide shelter; they create a foundation for health, stability, and opportunity," said Tom Collishaw, President and CEO of Self-Help Enterprises. "We know that when families have safe, stable housing, their physical and mental health outcomes improve. Health Net's $4 million investment has been instrumental in turning this vision into reality. We're proud to be building in Stanislaus County and look forward to welcoming residents home."
Self-Health Enterprises will also explore partnerships with service providers and community based organizations to connect future Morris Village residents to care and support services needed to thrive long after they move to Morris Village.
"As a registered nurse, I know that housing is a component of care and when families have opportunities to secure affordable housing, it improves their overall wellbeing and helps them thrive in our community," said Sue Zwahlen, Mayor of Modesto. "We appreciate Health Net's investment and Self-Help Enterprises' leadership in making this possible."
Since 2020, Health Net has committed $93 million to housing and homelessness initiatives across California, advancing long-term stability and improved health outcomes for communities most in need. Morris Village represents the latest announced initiative in that ongoing commitment.
About Health Net
Founded in California more than 45 years ago, Health Net, LLC ("Health Net"), a company of Centene Corporation, believes that every person deserves a safety net for their health, regardless of age, income, employment status or current state of health. Today, we provide health plans for individuals, families, businesses of every size and people who qualify for Medi-Cal or Medicare. With more than 117,000 of our network providers, Health Net serves more than three million members across the state. We also offer access to substance abuse programs, behavioral health services and managed healthcare products related to prescription drugs. We make these health plans and services available through Health Net and its subsidiaries: Health Net of California, Inc., Health Net Life Insurance Company and Health Net Community Solutions, Inc. These entities are wholly owned subsidiaries of Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to transforming the health of the communities we serve, one person at a time. Health Net and Centene Corporation employ more than 5,700 people in California who work at one of five regional Talent Hub offices. For more information, visit www.HealthNet.com.
Weekly Market HighlightsDuring the week, market breadth showed a slight skew towards decliners, with 4,779 advancing stocks compared to 4,802 declining stocks.
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreWhat if you like to use all three types of investing? The VGM Score is a combination of all Style Scores, making it one of the most comprehensive indicators to use with the Zacks Rank. It rates each stock on their combined weighted styles, which helps narrow down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +24% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Centene (CNC - Free Report) Centene Corporation is a well-diversified healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services.
CNC is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Medical stock. CNC has a Momentum Style Score of B, and shares are up 3.2% over the past four weeks.
For fiscal 2026, nine analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.46 to $3.47 per share. CNC boasts an average earnings surprise of +74.9%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, CNC should be on investors' short list.
Key Takeaways SpaceX IPO sparked market optimism, lifting the S&P 500 and boosting broader sector sentiment.Centene gained 48.3% YTD as improving Medicaid margins and AI initiatives support profits.DaVita and BrightSpring surged as operational gains and healthcare demand drive growth. The stock markets are seeing a renewed interest from investors, especially retailers, following the debut of Space Exploration Technologies Corp. (SPCX - Free Report) or SpaceX, which has been setting new records each day. The SpaceX IPO is the biggest ever IPO globally, raising an unprecedented $75 billion and beating the previous record of $29 billion set by Saudi oil firm Aramco in 2019.
The frenzy around this IPO led to a 4x oversubscription, attracting nearly $300 billion. SPCX secured a place among the world’s 10 largest companies on the day of its debut — a coveted position that most companies take decades to achieve.
The SpaceX IPO also made its owner, Elon Musk, the first and only trillionaire in the world. The second on the wealth list, Larry Page, co-founder of Google, a subsidiary of Alphabet (GOOGL - Free Report) , trails him by nearly $900 billion.
The S&P 500 Index is up nearly 1.5% since SpaceX IPO and has gained 9.7% so far this year. The plethora of upcoming large IPOs could continue to attract funds, likely pushing the index higher in the second half of 2026.
Although funds are likely to flow primarily in the technology sector, a positive S&P 500 Index should help drive a broader rally across several sectors. The following three companies — Centene (CNC - Free Report) , DaVita (DVA - Free Report) and BrightSpring Health Services, Inc. (BTSG - Free Report) — from the medical sector may benefit from a potential rally. Each of these companies currently sports a Zacks Rank #1 (Strong Buy) and has a VGM score of A or B, reflecting strong upside potential. You can see the complete list of today’s Zacks #1 Rank stocks here.
SpaceX & Upcoming IPOsThe SpaceX stock is already up 37% since its debut on June 11. Investors are dumping shares of other companies to become a part of this historic company. The strong optimism around the stock is unlikely to fizz out anytime soon.
Several indices, including NASDAQ 100, have fast-tracked the inclusion of SPCX into their constituent list. The company will be added to MSCI and Russell Indices by June-end, and will be included in the NASDAQ 100 on July 6. Apart from investor optimism, these inclusions are likely to drive additional investment into SPCX, as several passive funds that track these indices will begin adding the stock to their portfolios.
Following the SpaceX IPO, several other mega IPOs are slated to be launched in the second half of 2026, including AI giants — Anthropic and OpenAI. Alphabet is planning to raise approximately $80 billion through an equity sale soon. Alphabet plans to use the fund to support its AI-related capital expenditure.
Sound Prospect in Medical SectorApart from space exploration companies, a small section of medical companies is focusing on developing space medicine. Companies such as Eli Lilly, Merck, and Bristol Myers Squibb are conducting drug-development experiments on the International Space Station, while Vaxxinity is focused on developing vaccines and biologics.
However, these projects are unlikely to bring material impact to these companies anytime soon and should deliver results over the long term. Currently, the prospects of medical companies are being driven by the strong adoption of artificial intelligence and digital tools. The majority of large healthcare companies, as well as many smaller firms, are leveraging AI for drug development and integrating it into medical devices, thereby accelerating drug discovery and disease diagnosis.
The U.S. healthcare sector appears positioned for a stronger second half of 2026, supported by accelerating innovation cycles, favorable regulatory momentum, AI adoption, rising specialty drug demand, migration toward outpatient care, hospital capex recovery, and improving valuation attractiveness versus technology stocks. Per a Business Insider article, UBS and Franklin Templeton recently turned bullish on healthcare, citing structural demand growth, demographic tailwinds, and improving earnings visibility.
With a steady Fed rate, the accelerating capital spending by Hospitals is likely to continue in the second half of 2026, driving demand for robotic surgery, imaging, and advanced monitoring systems. Hospitals are also accelerating cloud migration and digital infrastructure modernization. The rising demand for cancer and rare-disease drugs is likely to drive Specialty pharmaceutical distribution. Moreover, growing home-healthcare demand is expanding direct-to-patient distribution opportunities.
The opening of the Strait of Hormuz following a peace deal between the United States and Iran is likely to bring energy prices down and clear the supply glut, benefiting all industries, including the medical sector.
The 5.8% decline so far this year in the Zacks Medical sector has led to attractive valuations. The sector has been trading at a discount to the S&P 500 Index since the beginning of 2025. The forward 12 month price-to-earnings (P/E F12M) ratio for the sector is 19.77X currently, below its five-year median of 20.45X.
P/E F12M Valuation: Medical sector vs S&P 500
Image Source: Zacks Investment Research
3 Medical Stocks to Bet on Right NowCentene, DaVita and BrightSpring Health Services have already surged so far this year amid these strong macro factors. Here, we discuss how the outlook for these companies is likely to evolve in the second half of 2026. While the Medical sector has declined 5.8% so far this year, these stocks have strongly outperformed the sector as well as the broader S&P 500 Index.
YTD Performance: CNC, DVA & BTSG
Image Source: Zacks Investment Research
Centene
Shares of Centene have gained 48.3% so far this year. The company appears well-positioned for a stronger performance in the second half of 2026. The improving Medicaid margins, disciplined medical cost management, and favorable Medicare execution continue increasing profitability.
Management raised the EPS guidance for 2026, following strong performance in the first quarter. Marketplace risk-adjustment benefits and AI-driven fraud detection initiatives could further support margin recovery, strengthening confidence in sustained earnings momentum.
Centene currently sports a Zacks Rank #1 (Strong Buy) and carries a VGM score of A. While the company’s sales are estimated to decline 1.9% year over year in 2026, earnings estimates reflect growth of 66.8%. Its earnings estimate for 2026 has improved 15.3% over the past 60 days. CNC’s earnings are likely to witness a CAGR of 37.1% over the next five year compared to the industry’s 18.5%. You can see the complete list of today’s Zacks #1 Rank stocks here.
Image Source: Zacks Investment Research
DaVita
DaVita’s shares have surged 83% in the year-to-date period. Its second-half 2026 outlook remains favorable, supported by improving dialysis treatment volumes, productivity-driven labor efficiencies, and expanding Integrated Kidney Care operations. The company raised full-year earnings guidance as clinic transfers from competitor closures, AI-led operational optimization, and sustained cost discipline are expected to drive stronger profitability and reinforce its resilient cash-generation profile.
DVA currently sports a Zacks Rank of 1 and carries a VGM score of A. The company’s sales and earnings estimates for 2026 suggest growth of 4.8% and 39.8%, respectively, compared to the year-ago period. Its earnings estimate for 2026 has improved 6.4% over the past 60 days. DVA’s earnings are likely to witness a CAGR of 20.2% over the next five year compared to the industry’s 12.4%.
Image Source: Zacks Investment Research
BrightSpring Health Services
BrightSpring is entering the second half of 2026 with strong momentum driven by rapid specialty pharmacy growth, expanding infusion services, and accelerating provider-services demand. Margin expansion from operational efficiencies, successful integration of acquired home-health assets, and a stronger balance sheet following divestiture proceeds position the company to capitalize on rising home-based healthcare demand and deliver robust earnings growth. The company’s shares have risen 76.9% so far this year.
BTSG currently flaunt a Zacks Rank of 1 and a VGM score of B. The company’s sales and earnings estimates for 2026 suggest growth of 16.6% and 67%, respectively, compared to the year-ago period. Its earnings estimate for 2026 has improved 10.6% over the past 60 days. BTSG’s earnings are likely to witness a CAGR of 46.5% over the next five year compared to the industry’s 15.5%.
Statewide grant program applications now open for qualifying non-profit organizations that connect Medicaid members to workforce training and employment opportunities
, /PRNewswire/ -- Managed Health Services (MHS), a managed care entity and a company of Centene Corporation (NYSE: CNC), has announced the launch of the MHS Serves Workforce Support Program, a new statewide funding opportunity designed to strengthen workforce development programs that help Medicaid members prepare for employment, increase their income and build long-term economic stability. Applications are now open through June 19, 2026 and can be submitted through the MHS Serves online portal at mhsserves.org.
The program will provide funding to nonprofit community-based organizations across Indiana that are working to address employment barriers and expand workforce pathways for Medicaid-eligible populations. Selected partners will be required to serve a minimum number of participants annually and report on workforce outcomes including employment placement, credential completion and job retention.
Funding will be awarded through two tiers designed to support both direct workforce services and broader regional coordination:
Tier 1 grants, ranging from $50,000 to $150,000, will support community-based organizations providing direct employment services and workforce training to individuals. Tier 2 grants, ranging from $300,000 to $500,000, will support organizations working at a regional level to coordinate workforce partners, align employers with training providers and strengthen workforce systems across multiple counties. Funding will focus on improving referral systems, aligning training programs with employer needs, and tracking employment outcomes across partner organizations. "Employment is one of the most powerful drivers of long-term health and stability," said MHS Plan President & Chief Executive Officer, Christina Hage. "MHS Serves Workforce Support Program will invest in the organizations that have a demonstrated track record of efforts helping individuals overcome barriers to employment while strengthening the systems that support workforce success."
Across Indiana, many Medicaid members want to work or advance in their careers but face barriers such as limited transportation, lack of childcare, unreliable internet access, gaps in education or credentials and limited professional networks.
The new workforce initiative comes as MHS prepares for new eligibility and enrollment changes to the Medicaid program established under H.R.1, including requiring certain adults to meet new work or community engagement standards. Working hand-in-hand with state and county partners, MHS will provide clear, timely guidance to its members and providers as this new policy takes shape.
The Workforce Support Program builds on the success of MHS Serves, a statewide initiative launched in 2023 by MHS in partnership with the Indiana Minority Health Coalition (IMHC) and Black Onyx Management to address health access and the social drivers of health through community-led solutions.
To date, MHS Serves projects have served 40 organizations in 21 Indiana counties by expanding digital healthcare access, creating 665 internet access points, and reaching over 10,000 people. In the last funding round, $1.2 million supported 19 organizations to improve youth healthcare and mental health resources, showing how targeted partnerships can remove barriers to care.
More information can be found at mhsserves.org or by contacting [email protected].
About MHS
Managed Health Services (MHS) is a managed care entity that has been proudly serving the state of Indiana for 30 years through the Hoosier Healthwise and Hoosier Care Connect Medicaid programs and the Healthy Indiana Plan (HIP) Medicaid alternative program. MHS also offers Ambetter Health in the Indiana health insurance marketplace, and Wellcare, a Medicare Advantage plan. All of our plans include quality, comprehensive coverage with a provider network you can trust. Visit mhsindiana.com to learn more. MHS is a Centene company, a leading healthcare enterprise that is committed to helping people live healthier lives.
Centene Monday confirmed plans to offer a "Voluntary Separation Program to support employees who may be considering a transition,” the company said in a statement June 15, 2026
Centene
Health insurer Centene, looking to cut costs after losing more than two million Obamacare health plan members, Monday confirmed plans to offer companywide buyouts to most employees.
Centene, which has 61,000 employees, didn’t disclose whether there was a specific number of workers that the company expected to take a buyout, which is being offered to “most” but not all employees, the company said.
“Centene is positioning the company to lead the future of healthcare - working to deliver a simpler and better experience for our members and partners while meeting the realities of today’s healthcare environment,” the company said in a statement. "Today we announced a Voluntary Separation Program to support employees who may be considering a transition.”
In April, Centene reported first quarter net income of more than $1.5 billion despite a drop of 2 million enrollees in individual coverage under the Affordable Care Act also known as Obamacare. Centene is one of the nation’s largest providers of Obamacare and the enrollment disclosure as part of the company’s first quarter earnings report was a snapshot into what health insurers and Americans who buy their coverage are facing after Congress and the Trump administration failed to renew enhanced subsidies.
Like other health insurers, Centene has been working to reduce administrative costs and other expenses. Centene’s first quarter earnings report indicated high healthcare costs that have been a drag in past earnings may be stabilizing somewhat as the company’s health benefits ratio, which is the percentage of premium spent on medical costs was down slightly to 87.3% for the first quarter of 2026 compared to 87.5% in the first quarter of 2025.
But it’s more difficult for health insurers to control expenses if the pool of patients paying premiums is dwindling. Centene said in April that its enrollment in “marketplace” plans it sells under the Ambetter brand dropped to 3.58 million at the end of the first quarter compared to 5.54 million at the end of last year and 5.62 million in the year ago quarter.
MORE FOR YOU
The big dip in Centene’s enrollment is what Democrats in Congress and health insurance industry analysts said would happen after Republicans in Congress and the Donald Trump White House wouldn’t agree to extend enhanced tax credits for buyers of Obamacare. A KFF analysis last fall said middle income Americans “as well as those with low incomes” will see “major out-of-pocket premium increases" if tax credits aren’t extended. And they are with customers reporting a doubling and even tripling of premiums for this year.
The subsidies, or tax credits, made health insurance premiums more affordable for individuals and were enhanced by the Biden administration and the Democratic-controlled Congress, which passed the Inflation Reduction Act of 2022, allowing more Americans to buy coverage. The enhanced subsidies helped enrollment in the ACA’s individual coverage, also known as Obamacare, eclipse a record 24 million Americans and help its popularity hit all-time highs.
Centene is scheduled to release its second quarter earnings report on July 28.
Centene said it offered buyouts to some employees on Monday, as the health insurer grapples with higher medical costs, funding cuts and membership declines.
"Centene is positioning the company to lead the future of healthcare - working to deliver a simpler and better experience for our members and partners while meeting the realities of today's healthcare environment," a company spokesperson said in a statement. "Today we announced a Voluntary Separation Program to support employees who may be considering a transition."
The company did not indicate how many employees it offered buyouts to, or how much it is aiming to reduce its workforce. Shares initially fell 4% after Bloomberg first reported the news on Monday.
Layoffs could follow if the company doesn't meet the target for voluntary separations, Bloomberg reported.
Centene is the largest Medicaid provider and is focused on other federal health plans through Medicare and the Affordable Care Act. The buyouts come after the company reported a decline in membership in the first quarter, down 6% year-over-year to 26.3 million, according to a filing.
Centene's ACA business lost about 2 million members in the first quarter compared to the end of 2025, primarily because Congress let enhanced federal subsidies in the program expire at the start of the year. The company in March also said it expects ACA membership to fall nearly 40% by the end of 2026, executives said in March at a Barclays conference.
Centene is bracing for the impact of more than $900 billion in cuts to Medicaid over a decade, and the broader insurance industry is still managing higher-than-expected medical costs in privately run Medicare plans.
Centene Corporation (NYSE:CNC) on Tuesday posted better-than-expected first-quarter earnings and 2026 outlook.
The company reported a first-quarter 2026 adjusted loss of $3.37, beating the consensus of $2.13 per share, approximately 50 cents better than the company's expectations. Centene's sales reached $49.94 billion, exceeding the consensus estimate of $47.53 billion.
In an investor call, the company said, "Medicaid results in the quarter were ahead of our previous projection, outperforming our HBR expectation in the period within that, we experienced a flu season that was lighter than our original forecast and saw a slight utilization benefit from weather events."
Centene expects fiscal 2026 adjusted earnings of more than $3.40, versus prior guidance of $3 per share, compared to the consensus of $3.02.
The company expects 2026 sales of $187.5 billion-$191.5 billion versus the consensus of $188.91 billion and prior guidance of $186.5 billion-$190.5 billion, including premium revenues between $171 billion and $175 billion (prior guidance of $170 billion-$174 billion).
Centene shares rose 7.1% to trade at $53.11 on Wednesday.
These analysts made changes to their price targets on Centene following earnings announcement.
B of A Securities analyst Kevin Fischbeck upgraded Centene from Underperform to Buy and raised the price target from $34 to $60. Truist Securities analyst David Macdonald maintained the stock with a Buy and raised the price target from $49 to $58. Barclays analyst Andrew Mok maintained the stock with an Overweight rating and raised the price target from $54 to $63. Considering buying CNC stock? Here’s what analysts think:
Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs
Centene rebounded in Q1-2026 with a significant improvement in its health benefits ratio, dropping to 87.3% from 94.3% in Q4-2025. CNC's Medicaid HBR improvement was driven by rate increases, medical cost management, and a mild flu season, though management remains cautious on sustainability. Despite a strong Q1-2026 beat, CNC raised full-year guidance less than the quarterly outperformance, reflecting uncertainty about trend continuation.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium includes access to the Zacks Style Scores as well.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Based on their value, growth, and momentum characteristics, each stock is assigned a rating of A, B, C, D, or F. The better the score, the better chance the stock will outperform; an A is better than a B, a B is better than a C, and so on.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum trading is all about taking advantage of upward or downward trends in a stock's price or earnings outlook, and these investors live by the saying "the trend is your friend." The Momentum Style Score can pinpoint good times to build a position in a stock, using factors like one-week price change and the monthly percentage change in earnings estimates.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
#1 (Strong Buy) stocks have produced an unmatched +23.93% average annual return since 1988, which is more than double the S&P 500's performance over the same time frame. However, the Zacks Rank examines a ton of stocks, and there can be more than 200 companies with a Strong Buy rank, and another 600 with a #2 (Buy) rank, on any given day.
With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy.
A stock with a #4 (Sell) or #5 (Strong Sell) rating, for instance, even one with Scores of A and B, will still have a declining earnings forecast, and a greater chance its share price will fall too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Centene (CNC - Free Report) Centene Corporation is a well-diversified healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services.
CNC is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.
Momentum investors should take note of this Medical stock. CNC has a Momentum Style Score of B, and shares are up 51.3% over the past four weeks.
Eight analysts revised their earnings estimate upwards in the last 60 days for fiscal 2026. The Zacks Consensus Estimate has increased $0.46 to $3.42 per share. CNC boasts an average earnings surprise of +74.9%.
With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, CNC should be on investors' short list.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today May 7th:
Centene (CNC - Free Report) : This well-diversified healthcare company, that primarily provides a set of services to the government sponsored healthcare programs, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.5% over the last 60 days.
Centene has a PEG ratio of 1.03 compared with 1.47 for the industry. The company possesses a Growth Score of A.
Petco Health and Wellness Co. (WOOF - Free Report) : This company, which is a fully-integrated health and wellness company for pets, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 35.7% over the last 60 days.
Petco Health and Wellness has a PEG ratio of 1.30 compared with 2.46 for the industry. The company possesses a Growth Score of A.
Valero Energy (VLO - Free Report) : This company, which is the largest independent refiner and marketer of petroleum products in the United States, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 95.7% over the last 60 days.
Valero Energy has a PEG ratio of 0.39 compared with 0.50 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
The funding is made available through an annual program that addresses barriers to healthcare.
, /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE: CNC), has announced the 2026 recipients of its annual grant program. In total, $100,000 in funding will be provided to 10 organizations, in 10 communities across Texas, to help address the needs of low-income neighborhoods, families, and individuals.
"We're proud to support the meaningful work of community-based organizations across Texas through our annual grant program," said Dr. Susan Mills, Sr. Vice President of Population Health & Clinical Outcomes. "We want to thank all the organizations that applied for these grants and look forward to partnering with many of them in the months ahead."
Since 2018, Superior has provided more than $1.3 million in funding to dozens of community partners through its grant program to help address non-medical drivers of health. Each grant recipient will support at least one of these areas:
Housing Stability & Support: Programs that reduce housing insecurity and improve living conditions for Medicaid members. Food Security & Nutrition: Programs that improve access to nutritious food and address emergency food needs for vulnerable populations. Health Care Access & Literacy: Programs that reduce barriers to care and improve health outcomes through education, navigation, and support services. The following organizations will each receive a $10,000 grant:
Organization
Location
Grant Purpose
Brighter Bites
San Antonio
Provides access to fresh food and nutrition education programming at six San Antonio schools during the 2026-27 school year.
Pregnancy Center of the Coastal Bend
Corpus Christi
Assists with prenatal care, health education, and parenting education for teenagers, women, and families facing an unplanned pregnancy.
Food Care Center
Killeen
Increases access to nutritious food for individuals and families, including emergency food distributions for seniors, veterans, and individuals eligible for Medicaid.
Food For All Project
Pflugerville
Enhances the ability to purchase food from wholesalers to meet increasing needs throughout the Central Texas community.
Hugging Heart Solutions
Nacogdoches
Provides essential infant supplies, such as diapers and wipes, as well as connections to local support services that promote health, stability, and self-sufficiency.
Lamesa Boys & Girls Club
Lamesa
Offers access to healthy breakfast and lunch for children who do not receive meals on Friday, filling a gap for students during a four-day school week in the district.
Martha's Home
Amarillo
Supports the Present Needs Future Success program to provide utility assistance, rental assistance, and emergency shelter for families experiencing housing instability.
Paso del Norte Center of Hope
El Paso
Supports the HOPE Restorative Housing Program to provide housing assistance and advocacy for survivors of trafficking facing homelessness, unsafe conditions, and instability.
Silver Ribbon Community Partners
McAllen
Provides financial assistance to seniors and adults with disabilities, including short-term utility support, rental assistance, application fees, and security deposits.
Wisdom Room With Royalty
Dallas
Assists with utility support and rental assistance for low-income seniors, including utility bills, to ensure they have access to essential services.
To learn more about this program, visit the Superior HealthPlan grants webpage.
About Superior HealthPlan
For more than 25 years, Superior HealthPlan has offered high-quality health care to Texans, and is now a leading managed care company providing services to more than 1.5 million people. Committed to transforming the health of the communities we serve, one person at a time, Superior supports active local involvement in all 254 Texas counties with 3,700 employees throughout the state. Since 2020, Superior has contributed $12.3 million in grants, sponsorships, and employee giving, helping support low-income communities. Superior is a company of Centene, a leading healthcare enterprise that is committed to helping people live healthier lives. For more information, visit www.SuperiorHealthPlan.com.
"America's Best Customer Service in Financial Services 2026" award recognizes companies delivering strong customer service based on nationwide consumer feedback SACRAMENTO, Calif., May 26, 2026 /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), has been named one of America's Best Customer Service in Financial Services 2026, a national recognition published by USA TODAY in partnership with independent research firm Plant‑A Insights Group.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
It also includes access to the Zacks Style Scores.
What are the Zacks Style Scores? The Zacks Style Scores, developed alongside the Zacks Rank, are complementary indicators that rate stocks based on three widely-followed investing methodologies; they also help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.
Growth ScoreGrowth investors are more concerned with a stock's future prospects, and the overall financial health and strength of a company. Thus, the Growth Style Score analyzes characteristics like projected and historic earnings, sales, and cash flow to find stocks that will see sustainable growth over time.
Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.
VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.
How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.
Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +23.7% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.
Since the Scores were created to work together with the Zacks Rank, the direction of a stock's earnings estimate revisions should be a key factor when choosing which stocks to buy.
Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: Centene (CNC - Free Report) Centene Corporation is a well-diversified healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services.
CNC is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of A.
It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 16.51; value investors should take notice.
Nine analysts revised their earnings estimate higher in the last 60 days for fiscal 2026, while the Zacks Consensus Estimate has increased $0.46 to $3.47 per share. CNC also boasts an average earnings surprise of +74.9%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, CNC should be on investors' short list.
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today May 28th:
Pitney Bowes (PBI - Free Report) : This global technology company, which is powering billions of transactions - physical and digital - in the connected and borderless world of commerce, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11% over the last 60 days.
Pitney Bowes has a PEG ratio of 0.70 compared with 0.80 for the industry. The company possesses a Growth Score of A.
Centene (CNC - Free Report) : This well-diversified healthcare company, that primarily provides a set of services to the government sponsored healthcare programs, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.3% over the last 60 days.
Centene has a PEG ratio of 0.46 compared with 1.04 for the industry. The company possesses a Growth Score of A.
Marathon Petroleum (MPC - Free Report) : This company, which is a leading independent refiner, transporter and marketer of petroleum products, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 72.9% over the last 60 days.
Marathon Petroleum has a PEG ratio of 0.40 compared with 0.47 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
Will Serve Thousands of Long Beach Residents Each Year with Recuperative Care Services and Pathways to Stable Housing
, /PRNewswire/ -- Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC, today announced a $10 million investment in Encompass Housing and National Health Care and Housing Advisors to support the expansion of the Community Care Campus Long Beach. The facility is a comprehensive, integrated care campus designed to improve health outcomes and accelerate pathways to stable housing for individuals experiencing homelessness.
The $10 million investment includes:
NHHA logo
Encompass logo $5 million from the Centene Foundation for major facility modernization $5 million from Health Net to support tenant improvements and the launch of new CalAIM-aligned care programs, including a dedicated Children & Families Recuperative Care program serving Medi-Cal members. "This investment underscores our commitment to strengthening the connection between health care and housing—because stability is foundational to health," said Dorothy M. Seleski, Medi-Cal Plan President at Health Net. "Together with National Health Care and Housing Advisors, and Encompass Housing we're supporting a community-based model that not only meets people where they are but also expands access to CalAIM services and family-centered recuperative care, helping individuals and families in Long Beach move toward long-term stability."
Health Net's $5 million investment will fund critical tenant improvements and compliance activities needed to launch new services at the Community Care Campus. This includes the demolition and renovation of approximately 5,000 square feet of the campus to enhance the Children & Families Recuperative Care program. Other improvements include electrical, elevator, fire safety and accessibility upgrades required for CalAIM programs and urgent medical services.
"In Long Beach we know that housing and health go hand-in-hand, which is why we're committed to thoughtful, community-based solutions that bring health care, housing, and supportive services together in one place," said Long Beach Mayor Rex Richardson. "The expansion of the Community Care Campus strengthens our ability to meet people where they are and connect residents to the care and stability they need to move forward."
The Community Care Campus will leverage reimbursements from Medi-Cal and Medicare managed care plans, hospital health systems and contracts with Los Angeles County agencies, including the Department of Public Health and Department of Mental Health. This blended funding model ensures year-round community services and continuity of care.
When fully operational, the expanded campus is expected to serve thousands of people each year—offering timely medical care, recuperative services and coordinated support so individuals and families can get help earlier, stay healthier and avoid reaching a crisis point.
"Investing in the Long Beach Community Care Campus demonstrates our commitment to providing real solutions for our neighbors experiencing homelessness," said Senator Lena Gonzalez (D-Long Beach). "This project will help ensure everyone in our community has access to the care, support, and pathways to stable housing they deserve."
Encompass Housing will continue to track outcomes related to housing stability, health equity and healthcare utilization, with biannual reporting and ongoing quality improvement to ensure accountability and continuous learning.
"This transformative grant enables us to expand and modernize the Community Care Campus, ensuring we can offer integrated medical care, behavioral health, and housing services to thousands of individuals experiencing homelessness," said Deby Wolford, CEO of Encompass Housing. "Our partnership with Health Net and the Centene Foundation is helping create a sustainable, community-based model that improves lives and builds a healthier, more stable Long Beach for all."
"The Community Care Campus reflects what's possible when health care and housing are intentionally brought together to serve people with complex needs," said Paul Leon, CEO of National Healthcare and Housing Advisors. "We're building a model that connects clinical care with stable housing solutions—helping individuals both recover and move forward with greater stability and support."
The renovation will follow a phased construction schedule to ensure uninterrupted delivery of existing programs. Design and planning began in May 2025, with construction expected to be completed by September 2027. Improvements will include accessibility upgrades, elevator maintenance, modernized mechanical and electrical systems, enhanced technology infrastructure, and safety enhancements throughout the campus.
From 2020 to 2025, Health Net committed more than $247 million in funding to community-based organizations.
To learn more about Health Net's local commitments, visit www.bridgingthedivideca.com.
About Health Net
Founded in California more than 45 years ago, Health Net, LLC ("Health Net"), a company of Centene Corporation, believes that every person deserves a safety net for their health, regardless of age, income, employment status or current state of health. Today, we provide health plans for individuals, families, businesses of every size and people who qualify for Medi-Cal or Medicare. With more than 118,000 of our network providers, Health Net serves more than three million members across the state. We also offer access to substance abuse programs, behavioral health services and managed healthcare products related to prescription drugs. We make these health plans and services available through Health Net and its subsidiaries: Health Net of California, Inc., Health Net Life Insurance Company and Health Net Community Solutions, Inc. These entities are wholly owned subsidiaries of Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to transforming the health of the communities we serve, one person at a time. Health Net and Centene Corporation employ more than 5,700 people in California who work at one of five regional Talent Hub offices. For more information, visit www.HealthNet.com.
About Centene Foundation
The Centene Foundation (the "Foundation"), a private nonprofit focused on investing in economically challenged communities, is the philanthropic arm of Centene Corporation (NYSE: CNC) ("Centene"). The Foundation supports projects and initiatives strategically aligned with Centene's mission-driven culture and enhances the work Centene Corporation is doing to remove the barriers to wellness underserved and low-income populations face. The Foundation is committed to addressing social drivers of health and improving health equity in three distinct areas of focus: healthcare access, social services and education. To learn more, visit the Centene Foundation's website.
About Encompass Housing
Encompass Housing is a southern California-based nonprofit organization that provides interim housing, recuperative care, and supportive housing services for individuals experiencing homelessness and housing instability. Through housing navigation, case management, and coordinated connections to healthcare and community resources, Encompass Housing helps individuals recover, stabilize, and transition to permanent housing. Working in partnership with healthcare organizations, government agencies, and community stakeholders, the organization advances integrated solutions that improve health outcomes and promote long-term housing stability. For more information, please visit us at Encompass Housing.
About National Healthcare and Housing Advisors
National Healthcare and Housing Advisors (NHHA) is a for-profit LLC, founded on over two decades of working with some of the most complex and vulnerable populations. NHHA has a proven track record of providing equitable, community-centered housing and healthcare consulting and administrative services supporting the work of non-profits, health plans, and government agencies. NHHA's work further extends to the implementation of direct care programs for historically underserved communities, including people experiencing homelessness, seniors, justice-involved individuals, Medicaid and Medi-Cal enrollees, and those with complex medical, behavioral health, and social needs including serious mental illness (SMI) and substance use disorder (SUD). NHHA develops and operationalizes Community Care Campus models across California and beyond that integrate healthcare, housing, and supportive services in a single coordinated system, advancing scalable, whole-person solutions that improve health outcomes and accelerate pathways to housing stability. To learn more, please visit us at NHHA.
Community-based organizations and providers across Missouri can apply through July 10, 2026 for grants up to $100,000 ST. LOUIS, June 10, 2026 /PRNewswire/ -- Home State Health and the Centene Foundation today announced a new grant opportunity to support nonprofit, community-based organizations and providers working to address key social drivers of health across Missouri.
